Clinical trials
Recruiting Observational Peripheral Arterial Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 9 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular and Interventional Radiological Society of Europe | 2 |
| EndoCore Lab s.r.l. | 2 |
| HJN Sverige AB/Neko Health | 2 |
| Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Acotec Scientific Co., Ltd | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Asan Medical Center | 1 |
| Atrium Medical Corporation | 1 |
| Aventusoft, LLC. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 55 |
| Chronic Limb-Threatening Ischemia | 12 |
| Cardiovascular Diseases | 7 |
| Coronary Artery Disease | 6 |
| Diabetic Foot | 5 |
| Aortic Diseases | 3 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Peripheral Vascular Diseases | 3 |
| Arterial Occlusive Diseases | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.